APA (7th ed.) Citation

P, L., T, B., M, B., A, P., J, P., SD, R., . . . H, R. (2020). Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: Results from a 7-year, multicentre retrospective cohort study. Alimentary pharmacology & therapeutics, 52(3), 500. https://doi.org/10.1111/apt.15901

Chicago Style (17th ed.) Citation

P, Lampertico, et al. "Treatment with Tenofovir Disoproxil Fumarate or Entecavir in Chronic Hepatitis B Virus-infected Patients with Renal Impairment: Results from a 7-year, Multicentre Retrospective Cohort Study." Alimentary Pharmacology & Therapeutics 52, no. 3 (2020): 500. https://doi.org/10.1111/apt.15901.

MLA (9th ed.) Citation

P, Lampertico, et al. "Treatment with Tenofovir Disoproxil Fumarate or Entecavir in Chronic Hepatitis B Virus-infected Patients with Renal Impairment: Results from a 7-year, Multicentre Retrospective Cohort Study." Alimentary Pharmacology & Therapeutics, vol. 52, no. 3, 2020, p. 500, https://doi.org/10.1111/apt.15901.